These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6238530)

  • 41. The effect of nonsteroidal anti-inflammatory agents on E. coli-induced inflammation.
    Issekutz AC; Bhimji S
    Immunopharmacology; 1982 Feb; 4(1):11-22. PubMed ID: 7037680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective inhibitory actions of sodium-p-benzyl-4-[1-oxo-2-(4-chlorobenzyl)-3-phenyl propyl] phenyl phosphonate (N-0161) and indomethacin on the biosynthesis of prostaglandins and thromboxanes from arachidonic acid.
    Eakins KE; Kulkarni PS
    Br J Pharmacol; 1977 May; 60(1):135-40. PubMed ID: 884384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanism of action of nonsteroidal anti-inflammatory agents.
    Goodwin JS
    Postgrad Med; 1983 May; Spec No():23-31. PubMed ID: 6224141
    [No Abstract]   [Full Text] [Related]  

  • 44. Release of mediators of anaphylaxis: inhibition of prostaglandin synthesis and the modification of release of slow reacting substance of anaphylaxis and histamine.
    Engineer DM; Niederhauser U; Piper PJ; Sirois P
    Br J Pharmacol; 1978 Jan; 62(1):61-6. PubMed ID: 74266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of indomethacin on the activation and effector function of suppressor cells from tumor-bearing mice.
    Pope BL
    Cancer Immunol Immunother; 1985; 19(2):101-8. PubMed ID: 3157436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of nonsteroidal anti-inflammatory drugs on glycogenolysis in isolated hepatocytes.
    Brass EP; Garrity MJ
    Br J Pharmacol; 1985 Oct; 86(2):491-6. PubMed ID: 3863682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonsteroidal anti-inflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepatocyte growth factor production.
    Bamba H; Ota S; Kato A; Matsuzaki F
    Biochem Biophys Res Commun; 1998 Apr; 245(2):567-71. PubMed ID: 9571196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of release of prostaglandin E-like material by non-steroid and steroid anti-inflammatory drugs.
    Grodzińska L; Pancenko B; Gryclewski R
    Acta Biol Med Ger; 1976; 35(8-9):1099-100. PubMed ID: 1007758
    [No Abstract]   [Full Text] [Related]  

  • 49. Renal effects of nonsteroidal anti-inflammatory agents.
    Lifschitz MD
    J Lab Clin Med; 1983 Sep; 102(3):313-23. PubMed ID: 6411840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Augmentation of concanavalin A-induced immunosuppression by indomethacin.
    Badger AM; Griswold DE; Walz DT
    Immunopharmacology; 1982 Apr; 4(2):149-62. PubMed ID: 6211419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-steroidal anti-inflammatory agent inhibit the synthesis of IgM rheumatoid factor in vitro.
    Ceuppens JL; Rodriguez MA; Goodwin JS
    Lancet; 1982 Mar; 1(8271):528-30. PubMed ID: 6120390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostaglandin involvement in hypersensitivity of ischemic hearts to arrhythmogenic influence of ouabain.
    Moffat MP; Karmazyn M; Ferrier GR
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H57-63. PubMed ID: 3925797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of drugs on prostaglandin synthesis.
    Youlten LJ
    Rheumatol Rehabil; 1978; Suppl():47-52. PubMed ID: 364610
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of nonsteroidal anti-inflammatory drugs on ouabain toxicity.
    Wilkerson RD; Glenn TM
    Am Heart J; 1977 Oct; 94(4):454-9. PubMed ID: 410285
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects on gastric prostaglandin synthesis produced by fenbufen, a new nonsteroidal anti-inflammatory agent with low gastrointestinal toxicity.
    Birnbaum JE; Tolman EL; Sloboda AE; Sparano BM; McClintock DK
    Pharmacology; 1982; 25 Suppl 1():27-38. PubMed ID: 7111380
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacology of nonsteroidal anti-inflammatory drugs. Practical review for clinicians.
    O'Brien WM
    Am J Med; 1983 Oct; 75(4B):32-9. PubMed ID: 6356906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of prostaglandin E2, indomethacin, trifluoperazine and drugs affecting the cytoskeleton on collagenase production by cultured adherent rheumatoid synovial cells.
    Dayer JM; Roelke MS; Krane SM
    Biochem Pharmacol; 1984 Sep; 33(18):2893-9. PubMed ID: 6089839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of prostaglandin activity and synthesis by fenbufen (a new nonsteroidal antiinflammatory agent) and one of its metabolites.
    Tolman EL; Birnbaum JE; Chiccarelli FS; Panagides J; Sloboda AE
    Adv Prostaglandin Thromboxane Res; 1976; 1():133-8. PubMed ID: 826139
    [No Abstract]   [Full Text] [Related]  

  • 59. Modulatory effect of prostaglandin E2 on the immune response in mice, with special reference to anti-sperm immunity.
    Bratanov K; Tornyov A; Somlev B; Velev B
    Int J Fertil; 1986; 31(4):305-10. PubMed ID: 2878901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular basis for the inhibition of prostanoid biosynthesis by nonsteroidal anti-inflammatory agents.
    Smith WL; DeWitt DL; Shimokawa T; Kraemer SA; Meade EA
    Stroke; 1990 Dec; 21(12 Suppl):IV24-8. PubMed ID: 2175460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.